These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 17201626)
21. [Malnutrition in children with DAMP?]. Andersen LL Ugeskr Laeger; 2009 Mar; 171(10):824. PubMed ID: 19280776 [No Abstract] [Full Text] [Related]
22. Increase in Menstrual Cycle Length Induced by Extended-Release Methylphenidate in an Adolescent with Attention-Deficit/Hyperactivity Disorder. Mutlu C; Bahalı K; Gunes H; Adaletli H J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):860-861. PubMed ID: 26397126 [No Abstract] [Full Text] [Related]
23. Explosive outbursts associated with methylphenidate. Adrian N J Am Acad Child Adolesc Psychiatry; 2001 Jun; 40(6):618-9. PubMed ID: 11392335 [No Abstract] [Full Text] [Related]
24. Visual fields in children with attention-deficit/hyperactivity disorder before and after treatment with stimulants. Ghanizadeh A Acta Ophthalmol; 2010 Mar; 88(2):e56. PubMed ID: 19508459 [No Abstract] [Full Text] [Related]
25. Ritalin--on the bandwagon? Erasmus J S Afr Med J; 2003 Nov; 93(11):805. PubMed ID: 14677494 [No Abstract] [Full Text] [Related]
26. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)]. Golubchik P; Sever J; Weizman A Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124 [TBL] [Abstract][Full Text] [Related]
27. Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial. Zarinara AR; Mohammadi MR; Hazrati N; Tabrizi M; Rezazadeh SA; Rezaie F; Akhondzadeh S Hum Psychopharmacol; 2010 Nov; 25(7-8):530-5. PubMed ID: 20860068 [TBL] [Abstract][Full Text] [Related]
28. Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder. McGough JJ; McBurnett K; Bukstein O; Wilens TE; Greenhill L; Lerner M; Stein M J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):351-6. PubMed ID: 16768642 [TBL] [Abstract][Full Text] [Related]
29. Drugs and children. Pinkham JR ASDC J Dent Child; 2002; 69(1):10. PubMed ID: 12119805 [No Abstract] [Full Text] [Related]
30. Attention deficit hyperactivity disorder: part III. Ryan-Krause P J Pediatr Health Care; 2011; 25(1):50-6. PubMed ID: 21147408 [No Abstract] [Full Text] [Related]
31. Effects of stimulant drugs on academic performance in hyperactive and learning disabled children. Gadow KD J Learn Disabil; 1983 May; 16(5):290-9. PubMed ID: 6135736 [No Abstract] [Full Text] [Related]
32. The effects of stimulant medications for ADHD. Natl Bur Econ Res Bull Aging Health; 2014; (1):1-2. PubMed ID: 25141389 [No Abstract] [Full Text] [Related]
33. The Relationship between Acute Dyskinesia with a Single Dose of Methylphenidate and Recent Risperidone Discontinuation in a Child with Attention-Deficit/Hyperactivity Disorder. Ince E; Algedik P; Demirdogen ES; Emul M; Demir T J Child Adolesc Psychopharmacol; 2015 May; 25(4):378-9. PubMed ID: 25920038 [No Abstract] [Full Text] [Related]
34. Report of a 14-Year-Old Boy Whose Testosterone Level Decreased After Starting on Methylphenidate. Akaltun İ J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):181. PubMed ID: 26863036 [No Abstract] [Full Text] [Related]
35. ADHD, methylphenidate and driving: does some legislation endanger public health? Verster JC; Cox DJ J Psychopharmacol; 2008 May; 22(3):227-9. PubMed ID: 18541623 [No Abstract] [Full Text] [Related]
36. A symposium on Attention Deficit Hyperactivity Disorder (ADHD). Developments in treatment. Levy F Aust N Z J Psychiatry; 2002 Aug; 36(4):477-9. PubMed ID: 12169142 [No Abstract] [Full Text] [Related]